Effect of high dose inhaled corticosteroids on cell mediated immunity in patients with asthma

Allergologia et Immunopathologia

Volumn 40, Issue 2, 2012, Pages 100-103

  Lee, C ^a   Klaustermeyer, W B ^a  

^a VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

Author keywords

Asthma; Cell mediated immunity; Delayed type hypersensitivity skin test; Infection; Inhaled corticosteroids

Indexed keywords

FLUTICASONE; FLUTICASONE PROPIONATE; SALMETEROL;

ADULT; AGED; ARTICLE; ASTHMA; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; HUMAN; IMMUNE RESPONSE; INJECTION SITE REACTION; MALE; PRURITUS; SKIN TEST; UNSPECIFIED SIDE EFFECT;

ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; AGED; ASTHMA; CROSS-SECTIONAL STUDIES; DRUG DOSAGE CALCULATIONS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 84857651301     PISSN: 03010546     EISSN: 15781267     Source Type: Journal    
DOI: 10.1016/j.aller.2011.11.001     Document Type: Article

References (39)

1. National Asthma Education and Prevention Program Expert Panel Report 3: guidelines for the diagnosis and management of asthma; 2003.
2. Szefler S.J. Glucocorticoid therapy for asthma: clinical pharmacology. J Allergy Clin Immunol 1991, 88:147-165.
3. Pouw E.M., Prummel M.F., Oosting H., Roos C.M., Endert E. Beclomethasone inhalation decreases serum osteocalcin. BMJ 1991, 302:627-628.
4. Ip M., Lam K., Yam L., Kung A., Ng M. Decreased bone mineral density in premenopausal asthma patients receiving long-term inhaled steroid therapy for asthma. Chest 1994, 105:1722-1727.
5. Toogood J.H., Jennings B.H., Hodsman A.B., Baskerville J., Fraher L.I. Effects of dose and dosing schedule of inhaled budesonide on bone turnover. J Allergy Clin Immunol 1991, 88:572-580.
6. Wong C.A., Walsh L.J., Smith C.J., Wisniewski A.F., Lewis S.A., Hubbard R. Inhaled corticosteroid use and bone mineral density in patients with asthma. Lancet 2000, 355:1399-1403.
7. Hubbard R.B., Smith C.J., Smeeth L., Harrison T.W., Tattersfield A.E. Inhaled corticosteroid and hip fracture: a population based case-control study. Am J Resp Crit Care Med 2002, 166:1563-1566.
8. Hubbard R., Tattersfield A., Smith C., West J., Smeeth L., Fletcher A. Use of inhaled corticosteroids and risk of fracture. Chest 2006, 130:1082-1088.
9. Tabachnik E., Zadik Z. Diurnal cortisol secretion during therapy with inhaled beclomethasone dipropionate in children with asthma. J Pediatr 1991, 118:294-297.
10. Phillip M., Aviram M., Leiberman E., Zadik Z., Giat Y., Levy J., et al. Integrate plasma cortisol concentration in children with asthma receiving long term inhaled corticosteroids. Pediatr Pulmonol 1992, 12:84-89.
11. Wales D., Makker H., Kane J., McDowell P., O'Driscoll R. Systemic bioavailability and potency of high dose inhaled corticosteroids. Chest 1999, 115:1278-1284.
12. Wilson A.M., McFarlane L.C., Lipworth B.J. Dose response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics. Am J Respir Crit Care Med 1997, 156:1274-1277.
13. Lipworth B.J. Systemic adverse effects of inhaled corticosteroid therapy: a systemic review and meta-analysis. Arch Intern Med 1999, 159:941-955.
14. Casale T.B., Nelson H.S., Stricker W.E., Raff H., Newman K.B. Suppression of hypothalamic-pituitary-adrenal axis activity with inhaled flunisolide and fluticasone propionate in adult asthma patient. Ann Allergy Asthma Immunol 2001, 87:379-385.
15. White M., Crisalida T., Li H., Economides A., Kaliner M. Effects of long term inhaled corticosteroid on adrenal function in a patient with asthma. Ann Allergy Asthma Immunol 2006, 96:437-444.
16. Wolthers O.D., Pedersen S. Growth of asthmatic children during treatment with budesonide: a double blind trial. BMJ 1991, 303:163-165.
17. McCowan C., Neville R.G., Thomas G.E. Effect of asthma and its treatment on growth: four year follow up of cohort of children from general practices in Tayside, Scotland. BMJ 1998, 316:668-672.
18. Agertoft L., Pedersen S. Effect of long term treatment with inhaled budesonide on adult height in children with asthma. N Engl J Med 2000, 343:1064-1069.
19. Cumming R.G., Mitchell P., Leeder S.R. Use of inhaled corticosteroids and risk of cataracts. N Engl J Med 1997, 337:8-14.
20. Garbe E., Suissa S., Lelorier J. Association of inhaled corticosteroid use with cataract in elderly patients. JAMA 1998, 280:539-543.
21. Smeeth L., Boulis M., Hubbard R., Fletcher A.E. A population based case-controlled study of cataracts and inhaled corticosteroids. Br J Opthalmol 2003, 87:1247-1251.
22. Min D.I., Monaco A.P. Complications associated with immunosuppressive therapy. Pharmacotherapy 1991, 11:119S-125S.
23. Mukwaya G. Immunosuppressive effects and infections associated with corticosteroid therapy. Pediatr Infect Dis J 1988, 7:499-504.
24. Haanes O.C., Bergmann A. Tuberculosis emerging in patients treated with corticosteroids. Eur J Respir 1983, 64:294-297.
25. Bovornkitti S., Kangsadal P., Sathirapat P., Oonsombatti P. Reversion and reconversion rate of tuberculin skin reactions in correlation with the use of prednisone. Dis Chest 1960, 38:51-53.
26. Janis E.M., Allen D.W., Glesby M.J., Carey L.A., Mundy L.M., Gopalan R., et al. Tuberculin skin test reactivity, anergy, and HIV infection in hospitalized patients. Am J Med 1996, 100:186-192.
27. Woeltje K.F., Kilo C.M., Johnson K., Primack J., Fraser V.J. Tuberculin skin testing of hospitalized patients. Infect Control Hosp Epidemiol 1997, 18:561-565.
28. Pinto-Powell R., Olivier K.N., Marsh B.J., Donaldson S., Worth-Parker H., Boyle W., et al. Skin testing with Mycobacterium avium to identify infection with M avium complex in patients with cystic fibrosis. Clin Infect Dis 1996, 22:560-562.
29. Claman H.N. Glucocorticosteroids 2: the clinical responses. Hosp Pract 1983, 7:143-151.
30. Cupps T.R., Fauci A.S. Corticosteroid-mediated immunoregulation in man. Immunol Rev 1982, 65:133-147.
31. Parrillo J.E., Fauci A.S. Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol 1979, 19:179-201.
32. Levy J., Zalkinder I., Kuperman O., Skibin A., Apte R., Bearman J.E., et al. Effect of prolonged use of inhaled steroids on the cellular immunity of children with asthma. J Allergy Clin Immunol 1995, 95:806-812.
33. Sharma K.C., Stevens D., Casey L., Kesten S. Effects of high-dose inhaled fluticasone propionate via spacer on cell-mediated immunity in healthy volunteers. Chest 2000, 118:1042-1048.
34. England R.W., Nugent J.S., Grathwohl K.W., Hagan L., Quinn J.M. High dose inhaled fluticasone and delayed hypersensitivity skin testing. Chest 2003, 123:1014-1017.
35. Horton D.J., Spector S.L. Clinical pulmonary tuberculosis in an asthmatic patient using a steroid aerosol. Chest 1977, 71:540-542.
36. Shaikh W.A. Pulmonary tuberculosis in patients treated with inhaled beclomethasone. Allergy 1992, 47:327-330.
37. Abzug M.J., Cotton M.F. Severe chickenpox after intranasal use of corticosteroids. J Pediatr 1993, 123:577-579.
38. FDA Medical Bulletin 1991;3.
39. American Academy of Allergy and Immunology Position statement: inhaled glucocorticoids and severe viral infections. J Allergy Clin Immunol 1993, 223-228.